Send me a link:

*Text messaging rates may apply.

 Dow Down 0.15% Nasdaq Down 0.31%

Arrowhead Research Corp. (ARWR)

-NasdaqGS
10.75 Down 0.49(4.36%) 12:52PM EDT - Nasdaq Real Time Price
Prev Close:11.24
Open:11.20
Bid:10.73 x 200
Ask:10.75 x 600
1y Target Est:28.10
Beta:2.84
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:10.62 - 11.29
52wk Range:3.10 - 27.63
Volume:868,448
Avg Vol (3m):1,885,270
Market Cap:557.63M
P/E (ttm):N/A
EPS (ttm):-1.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARWRDown 4.36%557.63M
APNT 0.00%6.75M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3,331.68
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-0.94
Quarterly EPS Est (Jun-14) :-0.22
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-1.44

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company’s product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback